We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic (IMPACCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04979897
Recruitment Status : Recruiting
First Posted : July 28, 2021
Last Update Posted : July 28, 2021
Sponsor:
Collaborators:
Clinica Alemana de Santiago
Clínica INDISA
Clínica BUPA
Hospital del Salvador
Hospital Regional Dr. Leonardo Guzmán de Antofagasta
Hospital San Pablo de Coquimbo
Hospital Metropolitano
Information provided by (Responsible Party):
Ana Cristina Castro, Universidad del Desarrollo

Brief Summary:

Intensive care unit (ICU) survivors and their families frequently present mental, cognitive and physical impairments lasting years. The ongoing pandemic could affect the duration, variety, and severity of these impairments. Our aim is to determine the impact of the COVID-19 pandemic on the physical, mental, and cognitive health of survivors, the experience of their families and their treating healthcare professionals in the long-term.

This is a prospective, multicentre, mixed-methods cohort study in seven Chilean ICUs. The perceptions of family members regarding the ICU stay and the later recovery will be explored 3 months after discharge. Health care professionals will be invited to discuss the challenges faced during the pandemic using semi-structured interviews.


Condition or disease Intervention/treatment
Covid19 Critical Care Postintensive Care Syndrome Other: Intensive care unit stay during the COVID-19 pandemic

Layout table for study information
Study Type : Observational
Estimated Enrollment : 450 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic (IMPACCT COVID-19): a Prospective, Multicentre, Mixed-methods Cohort Study
Actual Study Start Date : October 5, 2020
Estimated Primary Completion Date : November 2, 2021
Estimated Study Completion Date : February 2, 2022

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Intensive care unit stay during high bed occupancy in the COVID-19 pandemic
Adult patients (≥18 years old) who are mechanically ventilated for at least 48 hours in one of the participating ICUs during a high bed occupancy in the pandemic
Other: Intensive care unit stay during the COVID-19 pandemic
Patients will be screened daily for a potential ICU discharge. Each site coordinator, which is a clinician physiotherapist responsible for the site, will check that the patient is delirium-free (CAM-ICU negative) and cooperative (i.e. using 5 standardised questions: open [close] your eyes; look at me; open your mouth and stick out your tongue; nod your head; raise your eyebrows when I have counted up to five) within 72 hours from ICU discharge. Every patient deemed eligible will be invited to participate through a face-to-face visit by the assigned evaluator, receiving verbal and written information about the study

Intensive care unit stay during low bed occupancy in the COVID-19 pandemic
Adult patients (≥18 years old) who are mechanically ventilated for at least 48 hours in one of the participating ICUs during a low bed occupancy in the pandemic
Other: Intensive care unit stay during the COVID-19 pandemic
Patients will be screened daily for a potential ICU discharge. Each site coordinator, which is a clinician physiotherapist responsible for the site, will check that the patient is delirium-free (CAM-ICU negative) and cooperative (i.e. using 5 standardised questions: open [close] your eyes; look at me; open your mouth and stick out your tongue; nod your head; raise your eyebrows when I have counted up to five) within 72 hours from ICU discharge. Every patient deemed eligible will be invited to participate through a face-to-face visit by the assigned evaluator, receiving verbal and written information about the study




Primary Outcome Measures :
  1. World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) [ Time Frame: 6 months after the ICU discharge ]
    The WHODAS 2.0 is a self-reported disability questionnaire based on the International Classification of Functioning, Disability, and Health (ICF). It includes 36 questions, organised under six domains (cognition, mobility, self-care, getting along, life activities and participation). Each question must be answered based on the perceived difficulty for performing activities using a 5-point scale (none, mild, moderate, severe and extreme)


Secondary Outcome Measures :
  1. Clinical Frailty Scale [ Time Frame: Within 72 hours from ICU discharge ]
    The CFS evaluates specific domains including physical functioning, activities of daily living (ADL), instrumental ADL, assistance for personal care, comorbidities, and cognition to generate a frailty score using a 9-point scale ranging from 1 (very fit) to 9 (terminally ill). A score greater than 4 is considered fragile

  2. Medical Research Council Sum Score (MRC-SS) [ Time Frame: Within 72 hours from ICU discharge ]
    standardised examination of six muscle groups bilaterally (i.e. shoulder abduction, elbow flexion, wrist extension, hip flexion, knee extension and dorsiflexion)

  3. Functional Status Score for the Intensive Care Unit (FSS-ICU) [ Time Frame: Within 72 hours from ICU discharge ]
    The FSS-ICU is a mobility instrument to score the level of physical assistance required when performing five functional activities: rolling, transfer from supine to sit, sitting at the edge of the bed, transfer from sitting to stand, and walking

  4. Montreal Cognitive Assessment-Blind (MoCA blind) [ Time Frame: Within 72 hours from ICU discharge, 3 months, and 6 months after the ICU discharge ]
    The MoCA blind is a cognitive screening tool designed to detect cognitive dysfunction in five areas: memory, attention, language, abstraction and orientation. It requires 5 minutes to be completed

  5. Hospital Anxiety and Depression Scale (HADS) [ Time Frame: Within 72 hours from ICU discharge, 3 months, and 6 months after the ICU discharge ]
    The HADS is an interviewer or self-administered questionnaire designed to identify anxiety and depressive symptoms in a wide variety of in-hospital patients, which requires between 2 and 5 minutes to be completed

  6. Impact of Events Scale-Revised (IES-R) [ Time Frame: Within 72 hours from ICU discharge, 3 months, and 6 months after the ICU discharge ]
    The IES-R is an interviewer or self-administered questionnaire designed to measure the subjective distress caused by traumatic events that has been validated for critical illness survivors

  7. European Quality of Life Health Questionnaire (EQ-5D-3L) [ Time Frame: 3 months, and 6 months after the ICU discharge ]
    The EQ-5D-3L is an interviewer or self-administered questionnaire of health status or health-related quality of life, including five domains: mobility, self-care, usual activities, pain/discomfort, anxiety/depression and global health state

  8. Employment status [ Time Frame: Within 72 hours from ICU discharge, 3 months, and 6 months after the ICU discharge ]
    The employment status will be evaluated using tailored questions regarding current occupation, working hours, and any changes to their employment situation as it has been used elsewhere

  9. Survival [ Time Frame: Within 72 hours from ICU discharge, 3 months, and 6 months after the ICU discharge ]
    Number of patients who survived

  10. Actigraphy [ Time Frame: 6 months after the ICU discharge ]
    To measure sedentary behaviour and physical activity

  11. Global Physical Activity Questionnaire (GPAQ) [ Time Frame: 6 months after the ICU discharge ]
    To measure sedentary behaviour and physical activity


Other Outcome Measures:
  1. Consent rate [ Time Frame: Every month during one year ]
    Number of patients who agreed to participate divided by the number of patients who meet selection criteria

  2. Cohort retention rate [ Time Frame: Every month during one year ]
    Number of patients who can be contacted and evaluated



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Adults who were mechanically ventilated in the ICU, either with the diagnosis of COVID-19 or other causes
Criteria

Inclusion Criteria:

  • Adult patients (≥18 years old)
  • Mechanically ventilated for at least 48 hours

Exclusion Criteria:

  • Unable to walk independently 2 weeks prior to ICU admission (with or without a gait aid)
  • S5q < 5 or CAM-ICU positive within 72 hours after ICU discharge
  • Patient who do not understand or speak Spanish
  • Patient unable to communicate verbally
  • Burn or severe trauma as admission diagnosis
  • Any neurological disorder (i.e. spinal cord injury, stroke and brain tumours) as admission diagnosis
  • Transferred to a non-participating study centre before ICU discharge assessment
  • Recent prolonged hospital stay (extended by more than 3 months)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04979897


Contacts
Layout table for location contacts
Contact: Felipe González-Seguel, MSc 989540683 feligonzalezs@udd.cl
Contact: Ana Castro-Ávila, PhD anacastro@udd.cl

Locations
Layout table for location information
Chile
Hospital Regional Dr. Leonardo Guzmán de Antofagasta Recruiting
Antofagasta, Chile
Contact: Yerko Villagra         
Principal Investigator: Yerko Villagra         
Sub-Investigator: Pilar Castro         
Hospital San Pablo de Coquimbo Recruiting
Coquimbo, Chile
Contact: Eduardo González         
Principal Investigator: Eduardo González         
Clínica Alemana de Santiago Recruiting
Santiago, Chile
Contact: Agustín Camus-Molina, MSc         
Principal Investigator: Agustín Camus-Molina, MSc         
Sub-Investigator: Felipe González-Seguel, MSc         
Clínica BUPA Recruiting
Santiago, Chile
Contact: Javiera Aguilera         
Principal Investigator: Javiera Aguilera         
Sub-Investigator: Joaquín Olave         
Clínica INDISA Recruiting
Santiago, Chile
Contact: Felipe Muñoz-Muñoz, MSc         
Principal Investigator: Felipe Muñoz-Muñoz, MSc         
Hospital del Salvador Recruiting
Santiago, Chile
Contact: Camilo Cáceres         
Principal Investigator: Camilo Cáceres         
Sub-Investigator: Macarena Leiva-Corvalán         
Hospital Metropolitano Recruiting
Santiago, Chile
Contact: Fernanda Baus         
Principal Investigator: Fernanda Baus         
Sponsors and Collaborators
Universidad del Desarrollo
Clinica Alemana de Santiago
Clínica INDISA
Clínica BUPA
Hospital del Salvador
Hospital Regional Dr. Leonardo Guzmán de Antofagasta
Hospital San Pablo de Coquimbo
Hospital Metropolitano
Investigators
Layout table for investigator information
Principal Investigator: Ana Castro-Ávila, PhD Universidad del Desarrollo
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Ana Cristina Castro, Visiting lecturer, Universidad del Desarrollo
ClinicalTrials.gov Identifier: NCT04979897    
Other Study ID Numbers: 2020-78
First Posted: July 28, 2021    Key Record Dates
Last Update Posted: July 28, 2021
Last Verified: July 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Ana Cristina Castro, Universidad del Desarrollo:
Covid19
Critical care
Postintensive Care Syndrome
Rehabilitation
Follow-up
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases